Rebecca M. Ricklis

发表

A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.

M. McDevitt, B. Smith, J. Karp, 2007, Blood.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models

L. Sokoll, J. Isaacs, D. Rosen, 2003, The Prostate.

Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)‐activated thapsigargin prodrug

H. Lilja, J. Isaacs, D. Rosen, 2006, The Prostate.

Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer.

H. Lilja, U. Reineke, D. Rosen, 2004, Molecular cancer therapeutics.

Phase I dose‐escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias

R. Arceci, A. Narendran, L. Gore, 2012, Pediatric blood & cancer.

Phase 1 dose‐escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemias

M. McDevitt, B. Smith, J. Karp, 2012, British journal of haematology.

Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia : a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib ( R 115777 , Zarnestra ) combined with etoposide

D. Loegering, K. Flatten, N. T. Dai, 2008 .

Structure-function analysis of the antioxidant properties of haptoglobin.

A. Levy, N. Levy, M. Melamed-Frank, 2001, Blood.

Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.

D. Loegering, K. Flatten, J. Karp, 2009, Blood.

Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human

Simon A. Williams, S. Denmeade, S. Aggarwal, 2006, The Prostate.

Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.

D. Loegering, K. Flatten, N. T. Dai, 2009, Blood.